Home > Insider Trading > Filing (0001209191-19-006639)

Filing Details

Accession Number:: 0001209191-19-006639
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-01 20:35:14
Reporting Period:: 2019-01-31

Accepted Time:: 2019-02-01 20:35:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
897448	Amarin Corp Plc	AMRN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1289884	B Steven Ketchum	C/O Amarin Pharma, Inc. 1430 Route 206 Bedminster NJ 07921	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2019-01-31	2,604	$1.40	343,901	No	4	M	Direct
Ordinary Shares	Acquisiton	2019-01-31	4,167	$2.50	348,068	No	4	M	Direct
Ordinary Shares	Acquisiton	2019-01-31	2,770	$2.95	350,838	No	4	M	Direct
Ordinary Shares	Disposition	2019-01-31	9,541	$17.49	341,297	No	4	S	Direct
Ordinary Shares	Acquisiton	2019-01-31	26,666	$0.00	367,963	No	4	M	Direct
Ordinary Shares	Acquisiton	2019-01-31	29,000	$0.00	396,963	No	4	M	Direct
Ordinary Shares	Acquisiton	2019-01-31	26,000	$0.00	422,963	No	4	M	Direct
Ordinary Shares	Disposition	2019-01-31	40,482	$16.94	382,481	No	4	F	Direct
Ordinary Shares	Disposition	2019-02-01	27,989	$17.06	354,492	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2019-01-31	2,604	$0.00	2,604	$1.40
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2019-01-31	4,167	$0.00	4,167	$2.50
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2019-01-31	2,770	$0.00	2,770	$2.95
Ordinary Shares	Restricted Stock Units	Disposition	2019-01-31	26,666	$0.00	26,666	$0.00
Ordinary Shares	Restricted Stock Units	Disposition	2019-01-31	29,000	$0.00	29,000	$0.00
Ordinary Shares	Restricted Stock Units	Disposition	2019-01-31	26,000	$0.00	26,000	$0.00
Ordinary Shares	Restricted Stock Units	Acquisiton	2019-02-01	38,200	$0.00	38,200	$0.00
Ordinary Shares	Stock Option (Right to Buy)	Acquisiton	2019-02-01	53,500	$0.00	53,500	$16.88

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,250	2026-01-31	No	4	M	Direct
20,831	2025-07-06	No	4	M	Direct
67,000	2027-01-31	No	4	M	Direct
0		No	4	M	Direct
29,000		No	4	M	Direct
52,000		No	4	M	Direct
38,200		No	4	A	Direct
53,500	2029-02-01	No	4	A	Direct

Footnotes

Multiple reportable transactions are reported in the Form 4 including grants of options, grants of restricted stock units, exercise of previously granted options, vesting of previously granted restricted stock units and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Please see the section titled "Remarks" below for additional information.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.09 to $17.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
On February 1, 2016, the Reporting Person was granted 80,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2017, January 31, 2018 and January 31, 2019. The third and final vesting event occurred on January 31, 2019.
Not applicable.
On February 1, 2017, the Reporting Person was granted 87,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. The second vesting event occurred on January 31, 2019.
On February 1, 2018, the Reporting Person was granted 78,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020 and January 31, 2021. The first vesting event occurred on January 31, 2019.
Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.81 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016.
On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015.
On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2017.
Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021 and January 31, 2022.
On February 1, 2019, the Reporting Person was granted an option to purchase 53,500 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 16 equal quarterly installments starting on May 15, 2019.